Biotechnology
Insilico Medicine enters into a collaboration research with Astellas Pharma Inc. to apply novel generative artificial intelligence system for a conventionally challenging target family
TSUKUBA, Japan, April 28, 2020 /PRNewswire/ -- Insilico Medicine has announced that it has entered into a research collaboration agreement with Astellas Pharma Inc. to utilize Insilico Medicine's novel generative artificial intelligence technology aimed at accelerating development of candidates a...
2020-04-28 08:46
2330
Avidity Science™ Expands Water Purification Leadership Via Acquisition of Cascada™ and Operations Investment in Asia
WATERFORD, Wisconsin, April 28, 2020 /PRNewswire/ -- Today Avidity Science announces significant steps in expanding its global leadership in water purification solutions via the acquisition of theCascada Lab Water Purification product line from Pall®China and establishing manufacturing and distri...
2020-04-28 08:00
3898
WuXi Biologics Successfully Completes PFS Filling at its Robotic Aseptic Filling Facility
* First GMP facility in WuXi Biologics to use robotic aseptic filling line for biologics * Demonstrated diverse and flexible aseptic filling capability while maintaining high-quality and controlled filling accuracy as well as aseptic assurance WUXI, China, April 28, 2020 /PRNewswire/ -- WuXi ...
2020-04-28 08:00
2290
Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies
The new multiplex cytokine and cytotoxicity assays as a part of the Opto Cell Therapy Development 1.0 workflow will help users of the Berkeley Lights' platform develop cancer immunotherapies faster EMERYVILLE, Calif., April 28, 2020 /PRNewswire/ -- Today, Berkeley Lights, Inc., a leader in Digit...
2020-04-28 00:00
2732
Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19
Enumeration of Circulating Endothelial Cells (CECs) with CELLSEARCH platform may offer a new tool for investigating the role of the damaged endothelium in SARS-CoV-2 infection and clinical manifestation BOLOGNA, Italy, April 27, 2020 /PRNewswire/ -- Menarini Silicon Biosystems, a global leader i...
2020-04-27 20:10
1559
Global Cord Blood Corporation Provides Further Update on COVID-19
HONG KONG, April 27, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 2019...
2020-04-27 19:00
9470
ERBA Mannheim Launches CE Marked COVID-19 Antibody ELISA Kits - FDA EUA Following Soon
LONDON, April 27, 2020 /PRNewswire/ -- In response to the global COVID-19 pandemic,Erba Mannheim today announced the development and imminent launch of itsErbaLisa® COVID-19 ELISA kits for detection of IgG and IgM antibodies to SARS-CoV-2. The assays have been designed for use either manually or ...
2020-04-27 08:00
2281
Novaerus Defend 1050 Proven to Reduce Coronavirus Surrogate by 99.99%
DUBLIN, April 27, 2020 /PRNewswire/ -- Novaerus, an Irish company that
manufactures and sells patented medical-grade, clean air solutions, has
announced successful independent test results for its most powerful solution,
theDefend 1050
2020-04-27 06:00
3640
BioChek Acquires BIOTECON, Creates Leading Global Player in Veterinary and Food Safety Solutions
REEUWIJK, Netherlands, April 25, 2020 /PRNewswire/ -- BioChek, the specialist company to offer innovative and user-friendly veterinary diagnostic tools, today announced the successful acquisition of BIOTECON, specialised in development and manufacturing of PCR based solutions for food safety dia...
2020-04-25 04:09
2696
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine
SEATTLE, April 24, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it is partnering with AdaptVac to develop and produce a COVID-19 vaccine. AdaptVac, together with its EU Horizon 2020 sponsored PREVENT-nCoV con...
2020-04-24 14:50
3502
Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC
SUZHOU, China, April 24, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jo...
2020-04-24 07:50
7138
Henlius receives EU GMP Certificate for HLX02 (Trastuzumab for Injection)
SHANGHAI, April 23, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's drug substance (DS) line and drug product (DP) line for HLX02 trastuzumab biosimilar have successfully passed the European United (EU) Good Manufacturing Practice (GMP) on-site inspectio...
2020-04-23 22:02
3637
MiRXES to mass produce and distribute A*STAR Singapore's tested and proven SARS-CoV-2 RT-PCR test
SINGAPORE, April 23, 2020 /PRNewswire/ -- MiRXES, a homegrown Singapore-based biotech, has received Provisional Authorisation from the Health Sciences Authority (HSA)Singapore, to supply the Fortitude Kit SARS-CoV-2 real-time RT-PCR[1] test. With technology licensed from Singapore's Agency for Sc...
2020-04-23 18:04
3178
Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs
BANGALORE, India; WILMINGTON, Delaware and ADELAIDE, Australia, April 23, 2020
/PRNewswire/ -- Bugworks Research Inc
2020-04-23 11:30
3144
OncoQuest Announces Signing of a Definitive Agreement to Sell Drug Portfolio to Dual Industrial for U.S. $300 Million and Commitment to Fund the Oregovomab Phase 3 Clinical Trial in Frontline Ovarian Cancer
EDMONTON, Alberta, April 23, 2020 /PRNewswire/ -- OncoQuest Inc., ("OncoQuest" or the "Company") a privately held, cancer immunotherapy company today announced that it has entered into a definitive agreement to sell its clinical and preclinical immunotherapy development assets to Dual Industrial ...
2020-04-23 01:38
8233
WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany
SHANGHAI and LEVERKUSEN, Germany, April 22, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisition deal with Bayer for a drug product manufacturing plant in Leverkusen,Ge...
2020-04-22 08:00
2244
Seegene's Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization
SEOUL, South Korea, April 22, 2020 /PRNewswire/ -- Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVID-19 disease. ...
2020-04-22 07:40
2482
FibroGenesis Announces the Filing of its 200th Patent for Fibroblast Cell Therapy Platform
Building on a World Leading Intellectual Property Position with the 200th Patent Filed Today HOUSTON, April 21, 2020 /PRNewswire/ -- FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts (HDFs), today ...
2020-04-21 21:13
1616
Linical and Alpha Cognition Announce Strategic Partnership to Position Alpha-1062 for Approval in the United States and Japan Alzheimer's Markets
STUART, Florida, April 21, 2020 /PRNewswire/ -- Linical Company Limited (Linical) and Alpha Cognition Inc. (ACI) today announced they have signed a partnering agreement whereby Linical will provide strategic consulting services and regulatory guidance for Alpha-1062, a new chemical entity aimed t...
2020-04-21 21:00
2733
Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex(TM) Aortic Valve Technology
REHOVOT, Israel, April 21, 2020 /PRNewswire/ -- Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating heart valve calcification, announced today it has closed a$27 million round of financing, led by Sofinnova Partners, a leading European life scie...
2020-04-21 09:00
2365
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 293 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
[Picked up by 279 media titles]
2024-11-08 20:11
Most Read
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
2024-11-11 21:00
5634
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
2024-11-08 20:11
5568
HOIANA RESORT & GOLF LAUNCHES PREMIUM HOIANA PICKLEBALL COURT
2024-11-08 00:18
5520
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5403